XML 326 R22.htm IDEA: XBRL DOCUMENT
v3.25.1

STOCK OPTIONS AND CONTRIBUTED SURPLUS | 12 Months Ended
--- | ---
Dec. 31, 2024
Stock Options And Contributed Surplus |
STOCK OPTIONS AND CONTRIBUTED SURPLUS | 13. STOCK OPTIONS AND CONTRIBUTED SURPLUS Stock Options On June 21, 2024, shareholders of the Company approved the amendment to the Company’s fixed 20% omnibus equity incentive plan (the “Omnibus Plan”). The Omnibus Plan provides flexibility to the Company to grant different forms of equity based incentive awards to directors, officers, employees and consultants. The Omnibus plan provides the Company with the choice of granting stock options (“Options”), share units (“Share Units”) and deferred share units (“DSUs”). The Omnibus Plan provides that the maximum number of common shares issuable pursuant to awards granted under the Omnibus Plan and pursuant to other previously granted awards is limited to 12,218,458 (the “Number Reserved”). Any subsequent increase in the Number Reserved must be approved by shareholders of the Company and cannot, at the time of the increase, exceed 20% of the number of issued and outstanding shares. Awards vest in accordance with the policies determined by the Board of Directors from time to time consistent with the provisions of the Omnibus Plan which grants discretion to the Board of Directors. POET TECHNOLOGIES INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Expressed in US Dollars) 13. STOCK OPTIONS AND CONTRIBUTED SURPLUS (Continued) Stock option transactions and the number of stock options outstanding were as follows: SCHEDULE OF STOCK OPTIONS OUTSTANDING
|  |  |  |  | Historical |
|  |  |  |  | Weighted Average |
|  | Number of |  |  | Exercise |
|  | Options |  |  | Price |
Balance, January 1, 2022 |  |  | 4,959,617 |  |  | $ | 4.40 |
Expired/cancelled |  |  | (117,438 | ) |  |  | 6.02 |
Exercised |  |  | (143,437 | ) |  |  | 2.85 |
Granted |  |  | 2,043,083 |  |  |  | 3.32 |
Balance, December 31, 2022 |  |  | 6,741,825 |  |  |  | 4.10 |
Expired/cancelled |  |  | (182,750 | ) |  |  | 4.66 |
Exercised |  |  | (268,356 | ) |  |  | 2.49 |
Granted |  |  | 1,002,170 |  |  |  | 4.11 |
Balance, December 31, 2023 |  |  | 7,292,889 |  |  |  | 3.92 |
Expired/cancelled |  |  | (184,996 | ) |  |  | 5.33 |
Exercised |  |  | (597,151 | ) |  |  | 1.28 |
Granted |  |  | 3,051,482 |  |  |  | 2.12 |
Modified options (1) |  |  | (7,153,358 | ) |  |  | 3.92 |
Repriced options (1) |  |  | 7,153,358 |  |  |  | 1.29 |
Balance, December 31, 2024 |  |  | 9,562,224 |  |  | $ | 1.47 |
(1) |  | During the year ended December 31, 2024, the Company amended 7,153,358 stock options granted to directors, officers, employees and consultants. The amended stock options were initially granted at prices ranging from CA$2.60 to CA$11.90. The amended stock options were repriced to CA$1.75.
During the year ended December 31, 2024, the Company recorded stock-based compensation of $5,469,369 (2023 - $4,201,444, 2022 - $4,436,604) relating to stock options that vested during the year. The stock options granted and re-priced were valued using the Black-Scholes option pricing model using the following assumptions: SCHEDULE OF STOCK OPTIONS ASSUMPTIONS
Re-priced stock options |
|  | 2024 |  |  | 2024 |  |  | 2023 |  |  | 2022 |
Weighted average exercise price |  | $ | 1.29 |  |  | $ | 2.12 |  |  | $ | 4.11 |  |  | $ | 3.32 |
Weighted average risk-free interest rate |  |  | 3.47 | % |  |  | 2.99% - 3.55% |  |  |  | 2.88% - 3.48% |  |  |  | 1.80% - 3.48% |
Weighted average dividend yield |  |  | 0 | % |  |  | 0 | % |  |  | 0 | % |  |  | 0 | %
Weighted average volatility |  |  | 83.70 | % |  |  | 85.73% - 86.97% |  |  |  | 82.17% - 82.45% |  |  |  | 83.51 | %
Weighted average estimated life |  |  | 6.4 years |  |  |  | 10 years |  |  |  | 10 years |  |  |  | 10 years |
Weighted average share price |  | $ | 1.29 |  |  | $ | 2.12 |  |  | $ | 4.11 |  |  | $ | 3.32 |
Share price on the various grant dates: |  | $ | 1.29 |  |  | $ | 4.05 - $4.63 |  |  | $ | 4.05 - $4.63 |  |  |  | $2.72 - $6.71 |
Weighted average fair value |  | $ | 0.96 |  |  | $ | 3.42 |  |  | $ | 3.42 |  |  | $ | 2.70 |
POET TECHNOLOGIES INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Expressed in US Dollars) 13. STOCK OPTIONS AND CONTRIBUTED SURPLUS (Continued) The underlying expected volatility was determined by reference to the Company’s historical share price movements, its dividend policy and dividend yield and past experience relating to the expected life of granted stock options. The weighted average remaining contractual life and weighted average exercise price of options outstanding and of options exercisable as at December 31, 2024 are as follows: SCHEDULE OF WEIGHTED AVERAGE REMAINING CONTRACTUAL LIFE AND WEIGHTED AVERAGE EXERCISE PRICE OF OPTIONS
Options Outstanding |  |  | Options Exercisable |
|  |  |  |  | Historical Weighted Average |  |  | Weighted Average Remaining |  |  |  |  |  | Historical Weighted Average |
Exercise |  | Number |  |  | Exercise |  |  | Contractual |  |  | Number |  |  | Exercise |
Range |  | Outstanding |  |  | Price |  |  | Life (years) |  |  | Exercisable |  |  | Price |
$0.76 - $1.22 |  |  | 6,510,742 |  |  | $ | 1.22 |  |  |  | 5.94 |  |  |  | 2,471,484 |  |  | $ | 1.22 |
$1.23 - $3.04 |  |  | 2,582,659 |  |  | $ | 1.68 |  |  |  | 9.39 |  |  |  | 208,245 |  |  | $ | 1.72 |
$3.05 - $5.00 |  |  | 468,823 |  |  | $ | 3.92 |  |  |  | 9.87 |  |  |  | - |  |  | $ | - |
|  |  | 9,562,224 |  |  | $ | 1.47 |  |  |  | 7.07 |  |  |  | 2,679,729 |  |  | $ | 1.26 |

X
- References No definition available. + Details
Name: | POET_StockOptionsAndContributedSurplusAbstract
Namespace Prefix: | POET_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for share-based payment arrangements. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 2 -IssueDate 2024-01-01 -Paragraph 44 -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2024-en-r&anchor=para_44&doctype=Standard -URIDate 2024-03-27 + Details
Name: | ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory
Namespace Prefix: | ifrs-full_
Data Type: | dtr-2022:textBlockItemType
Balance Type: | na
Period Type: | duration